Skip to content

Drug interactions

Dolutegravir + Efavirenz

Severity: Moderate

Dolutegravir and Efavirenz: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz induces UGT1A1 and CYP3A4, lowering dolutegravir concentrations and risking reduced antiviral efficacy. The combination is acceptable with dose adjustment rather than avoidance.

What this interaction means in plain words

Dolutegravir and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dolutegravir belongs to Anti Virals; Efavirenz belongs to Anti Virals.

Evidence level: High

Why it happens

Efavirenz induces UGT1A1 and CYP3A, increasing dolutegravir clearance.

What to do

Give dolutegravir 50 mg twice daily instead of once daily while efavirenz is co-administered. Monitor viral load, and return to the standard dose when efavirenz is stopped.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dolutegravir and Efavirenz, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dolutegravir with Efavirenz?

MediHelp rates the interaction as moderate. Dolutegravir and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz induces UGT1A1 and CYP3A4, lowering dolutegravir concentrations and risking reduced antiviral efficacy. The combination is acceptable with dose adjustment rather than avoidance.

How serious is the interaction between Dolutegravir and Efavirenz?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Give dolutegravir 50 mg twice daily instead of once daily while efavirenz is co-administered. Monitor viral load, and return to the standard dose when efavirenz is stopped.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in